{
    "2019-12-29": [
        [
            {
                "time": "2019-12-23",
                "original_text": "【太平洋医药】第二轮全国集采方案公布，继续推荐景气度好，行业天花板高，不受政策影响/影响较小的细分领域",
                "features": {
                    "keywords": [
                        "全国集采",
                        "景气度",
                        "政策影响",
                        "细分领域"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-12-23",
                "original_text": "梳理与展望，盘点2019的“热点”与“冷门” -- 医药行业周报（2019.12.23-2019.12.29）",
                "features": {
                    "keywords": [
                        "热点",
                        "冷门",
                        "医药行业周报"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-01-01",
                "original_text": "中信建投策略首席分析师张玉龙：2020年“牛蹄”稍慢 两类股有机会",
                "features": {
                    "keywords": [
                        "中信建投",
                        "张玉龙",
                        "牛蹄",
                        "机会"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-12-31",
                "original_text": "来看看2019年资本市场十大风云董事长都有谁",
                "features": {
                    "keywords": [
                        "资本市场",
                        "风云董事长"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-12-28",
                "original_text": "第二批药品集中采购启动！涉及100多家药企，这份上市公司名单含金量最高",
                "features": {
                    "keywords": [
                        "药品集中采购",
                        "药企",
                        "上市公司名单"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-12-28",
                "original_text": "3股获买入评级 最新:恒瑞医药",
                "features": {
                    "keywords": [
                        "买入评级",
                        "恒瑞医药"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-12-28",
                "original_text": "机构称科技主题将引领A股走出结构性牛市",
                "features": {
                    "keywords": [
                        "科技主题",
                        "A股",
                        "结构性牛市"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-12-28",
                "original_text": "百济神州正式入局 国内PD-1单抗“4＋2”竞争局面形成",
                "features": {
                    "keywords": [
                        "百济神州",
                        "PD-1单抗",
                        "竞争局面"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-12-28",
                "original_text": "【国盛医药张金洋团队】周观点：肝素到底是周期还是成长？——兼论全球肝素产业链重构",
                "features": {
                    "keywords": [
                        "肝素",
                        "周期",
                        "成长",
                        "产业链重构"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-12-28",
                "original_text": "百元股成群结队来了！昔日“股王”半数股价腰斩，10只仅剩零头，最牛股飙涨超100倍",
                "features": {
                    "keywords": [
                        "百元股",
                        "股王",
                        "股价腰斩"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-12-28",
                "original_text": "第二轮全国带量采购方案出台，中选企业数进一步增加",
                "features": {
                    "keywords": [
                        "带量采购",
                        "中选企业数"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-12-28",
                "original_text": "【国信医药】新一轮国家药品集采文件公布，涉及33个新品种（行业重大事件快评）",
                "features": {
                    "keywords": [
                        "国家药品集采",
                        "新品种"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-12-28",
                "original_text": "A股科技龙头50强出炉！拿下A股6%市值，三年飞出3只十倍股",
                "features": {
                    "keywords": [
                        "A股科技龙头",
                        "市值",
                        "十倍股"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}